Research in the Chapkin lab focuses on dietary/microbial modulators related to the prevention of cancer and chronic inflammatory diseases. The lab has been continuously funded by the National Institutes of Health (NIH) for the past 35 years.
Most Recent ASN Achievement : Dr. Chapkin named American Society for Nutrition 2024 Fellow
Most Recent NIH Award: Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
TEXAS REGIONAL CENTER OF EXCELLENCE IN CANCER RESEARCH – TREC
The Chapkin Lab is excited to work with the Single Cell Science Data Core established through the Texas A&M University Regional Center of Excellence in Cancer Research – TREC.
TREC EVENTS: SPEAKER SEMINAR SERIES
To resume Fall 2024
RECENTLY PUBLISHED:
- American Society for Nutrition Foundation Announces Class of 2024 Fellows
April 1, 2024 by ASN Staff ASN’s Class of 2024… Read more: American Society for Nutrition Foundation Announces Class of 2024 Fellows - NEWS
- Texas A&M AgriLife researcher receives $4 million grant to study feeding intolerance in preterm infants
Novel noninvasive method allows for precise diagnosis of feeding intolerance… Read more: Texas A&M AgriLife researcher receives $4 million grant to study feeding intolerance in preterm infants - Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
Major Goals: Annotate host exfoliated mucosal cell transcriptome, i.e., exfoliome,… Read more: Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant - Texas A&M University Faculty Affairs
Congratulates Dr. Robert Chapkin for ASN Award
FOLLOW US ON X (formerly known as Twitter) @ChapkinLab
Congrats to the 2023 Mary Swartz Rose Investigator Awardees, shown here at the @nutritionorg #Nutrition2023 event in Boston yesterday! These awards are given for outstanding #research on the #safety & efficacy of bioactive compounds for human #health. https://t.co/RtGTwMQRrN pic.twitter.com/phLIP6JzyA— CRN (@CRN_Supplements) July 24, 2023
Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin https://t.co/wxCT8liokp— The Chapkin Lab (@ChapkinLab) August 23, 2023